Associations of dairy product consumption with mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Italy cohort.


Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
01 11 2019
Historique:
received: 29 10 2018
accepted: 12 07 2019
pubmed: 23 8 2019
medline: 3 4 2020
entrez: 23 8 2019
Statut: ppublish

Résumé

The relation of dairy product consumption to health and mortality is controversial. We investigated associations of consumption of various dairy products with mortality in the Italian cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Italy study. Dairy product consumption was assessed by validated semiquantitative FFQs. Multivariable Cox models stratified by center, age, and sex and adjusted for confounders estimated associations of milk (total, full fat, and reduced fat), yogurt, cheese, butter, and dairy calcium consumption with mortality for cancer, cardiovascular disease, and all causes. Nonlinearity was tested by restricted cubic spline regression. After a median follow-up of 14.9 y, 2468 deaths were identified in 45,009 participants: 59% from cancer and 19% from cardiovascular disease. No significant association of consumption of any dairy product with mortality was found in the fully adjusted models. A 25% reduction in risk of all-cause mortality was found for milk intake from 160 to 120 g/d (HR: 0.75; 95% CI: 0.61, 0.91) but not for the highest (>200 g/d) category of intake (HR: 0.95; 95% CI: 0.84, 1.08) compared with nonconsumption. Associations of full-fat and reduced-fat milk consumption with all-cause and cause-specific mortality were similar to those for milk as a whole. In this Italian cohort characterized by low to average milk consumption, we found no evidence of a dose-response association between milk consumption and mortality and also no association of consumption of other dairy products investigated with mortality.

Sections du résumé

BACKGROUND
The relation of dairy product consumption to health and mortality is controversial.
OBJECTIVES
We investigated associations of consumption of various dairy products with mortality in the Italian cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC)-Italy study.
METHODS
Dairy product consumption was assessed by validated semiquantitative FFQs. Multivariable Cox models stratified by center, age, and sex and adjusted for confounders estimated associations of milk (total, full fat, and reduced fat), yogurt, cheese, butter, and dairy calcium consumption with mortality for cancer, cardiovascular disease, and all causes. Nonlinearity was tested by restricted cubic spline regression.
RESULTS
After a median follow-up of 14.9 y, 2468 deaths were identified in 45,009 participants: 59% from cancer and 19% from cardiovascular disease. No significant association of consumption of any dairy product with mortality was found in the fully adjusted models. A 25% reduction in risk of all-cause mortality was found for milk intake from 160 to 120 g/d (HR: 0.75; 95% CI: 0.61, 0.91) but not for the highest (>200 g/d) category of intake (HR: 0.95; 95% CI: 0.84, 1.08) compared with nonconsumption. Associations of full-fat and reduced-fat milk consumption with all-cause and cause-specific mortality were similar to those for milk as a whole.
CONCLUSIONS
In this Italian cohort characterized by low to average milk consumption, we found no evidence of a dose-response association between milk consumption and mortality and also no association of consumption of other dairy products investigated with mortality.

Identifiants

pubmed: 31435641
pii: S0002-9165(22)01306-5
doi: 10.1093/ajcn/nqz183
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1220-1230

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © American Society for Nutrition 2019.

Auteurs

Valeria Pala (V)

Epidemiology and Prevention Unit, IRCCS National Cancer Institute Foundation, Milan, Italy.

Sabina Sieri (S)

Epidemiology and Prevention Unit, IRCCS National Cancer Institute Foundation, Milan, Italy.

Paolo Chiodini (P)

Medical Statistics Unit, Luigi Vanvitelli University of Campania, Naples, Italy.

Giovanna Masala (G)

Cancer Risk Factors and Lifestyle Epidemiology Unit, ISPRO, Florence, Italy.

Domenico Palli (D)

Cancer Risk Factors and Lifestyle Epidemiology Unit, ISPRO, Florence, Italy.

Amalia Mattiello (A)

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Salvatore Panico (S)

Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

Rosario Tumino (R)

Cancer Registry, ASP Ragusa, Ragusa, Italy.

Graziella Frasca (G)

Cancer Registry, ASP Ragusa, Ragusa, Italy.

Francesca Fasanelli (F)

Unit of Cancer Epidemiology, CeRMS, Department of Medical Sciences, University of Turin, Turin, Italy.

Fulvio Ricceri (F)

Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Unit of Epidemiology, Local Health Unit TO3, Grugliasco, Italy.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, IRCCS National Cancer Institute Foundation, Milan, Italy.

Sara Grioni (S)

Epidemiology and Prevention Unit, IRCCS National Cancer Institute Foundation, Milan, Italy.

Vittorio Krogh (V)

Epidemiology and Prevention Unit, IRCCS National Cancer Institute Foundation, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH